Autoantibodies directed to centromere protein F (CENP-F) were first reported in 1993 and their association with malignancy has been well documented. We present a case of this autoantibody detected in a 47-year-old female with BRCA1 gene mutation associated with bilateral breast cancer and ovarian cancer.